TrueCAGR

Colgate-Palmolive (India) Ltd.

NSE: COLPALBSE: 500830ISIN INE259A01022Face value ₹1standalone
₹1,761
−0.81% · 2026-11-20 · 52-wk ₹1,574–₹2,295
Source: BSE filings · Financials to FY2026 · 8 years of history · Data last updated: results filed 22 Oct 2026, prices to 20 Nov 2026 · How we calculate thisconsolidatedstandalone
Section 02 · Synthesis

What stands out?

The strongest observations the engine found, ranked. Every line is generated from the filed numbers by a fixed rule — no opinion, no estimate.

StrengthConcernWatchContext
StrengthTalking point

More profitable than peers

ROE of 81.6% is well above the personal care median of 19.9%.

Importance 63 / 95 · profitability

Strength

Consistently free-cash-flow positive

Free cash flow has been positive in 6 of the last 6 years.

Importance 44 / 95 · cash quality

Concern

Margins compressing

EBITDA margin fell from 34.7% to 32.5% of revenue.

Importance 40 / 95 · profitability

Section 03 · The company

Who is this company?

Classified by the exchange under Fast Moving Consumer Goods › Fast Moving Consumer Goods › Personal Products › Personal Care.

Market cap
₹47,888 cr
FY2026 revenue
₹6,035 cr
FY2026 net profit
₹1,325 cr
Net worth
₹1,584 cr
Total debt
₹0 crnet cash
EPS (basic)
₹48.73
Listed
NSE · BSE
Reporting
Ind-ASApr–Mar

Peer set used on this page: 3 personal care.

Section 04 · Business performance

Is the business growing?

Revenue grew 4.4% a year over 7 years, from ₹4,462 cr in FY2019 to ₹6,035 cr in FY2026. Net profit grew 8.0% a year over the same period.

Revenue & net profit — FY19 to FY26₹ crore · consolidated
₹'000 cr02457012REVENUENET PROFIT4k776FY195k816FY205k1,035FY215k1,078FY225k1,047FY236k1,324FY246k1,437FY256k1,325FY26
RevenueNet profit
Context

Revenue has compounded at 4.4% a year over 7 years (₹4,462 → ₹6,035) — steady rather than rapid.

Rule REVENUE_COMPOUNDED_MODERATE

Revenue growth per year
+4.4%over 7 years (FY19–FY26)
Revenue growth
−0.1%vs last year
Net profit growth
−7.8%vs last year
Change in net profit since FY19
+71%
Section 05 · Recent activity

What changed recently?

In Q2 FY27 (Jul–Sep 2026), revenue was ₹1,706 cr (up 12.3% on the same quarter last year) and net profit ₹342 cr (up 4.3%).

Quarterly results, the trailing-twelve-months snapshot, and verified corporate actions — kept separate from each other and from the annual story above. Every figure traces to a filed number; nothing here is external news or commentary.

Strength

Q2 FY27 revenue was ₹1,706 cr, up 12.3% from ₹1,520 cr in Q2 FY26 a year earlier.

Rule QTR_REVENUE_GROWTH_YOY

Concern

Q2 FY27 EBITDA margin was 29.0%, down 2.59 percentage points from 31.6% a year earlier.

Rule QTR_MARGIN_CHANGED_YOY

Strength

Q2 FY27 revenue of ₹1,706 cr is the highest of the 17 quarters on record for this company.

Rule QTR_REVENUE_AT_RECORD

A. Quarterly results

Latest quarters — Q3 '25 to Q2 '27₹ crore · standalone
₹'000 cr01122000REVENUENET PROFIT1k323Q3 '251k355Q4 '251k321Q1 '262k328Q2 '261k324Q3 '262k353Q4 '262k343Q1 '272k342Q2 '27
RevenueNet profit
QuarterRevenueYoYNet profitYoYNet margin
Q3 FY251,462+4.7%323−2.2%22.1%
Q4 FY251,463−1.8%355−6.5%24.3%
Q1 FY261,434−4.2%321−11.9%22.4%
Q2 FY261,520−6.2%328−17.1%21.6%
Q3 FY261,486+1.7%324+0.3%21.8%
Q4 FY261,595+9.1%353−0.5%22.1%
Q1 FY271,603+11.8%343+7.0%21.4%
Q2 FY271,706+12.3%342+4.3%20.0%

B. TTM snapshot

Trailing twelve months to 30 Sept 2026 · sum of the last 4 contiguous quarters

Revenue
₹6,391 crTTM
EBITDA
₹2,009 crTTM
EBIT
₹1,864 crTTM
PBT
₹1,832 crTTM
Net profit
₹1,362 crTTM

C. Corporate actions

2 Nov 2026DividendInterim Dividend - Rs. - 24.0000 — ₹24.00/share
1 Jun 2026DividendInterim Dividend - Rs. - 24.0000 — ₹24.00/share
3 Nov 2025DividendInterim Dividend - Rs. - 24.0000 — ₹24.00/share
28 May 2025DividendInterim Dividend - Rs. - 27.0000 — ₹27.00/share
4 Nov 2024DividendInterim Dividend - Rs. - 24.0000 — ₹24.00/share
22 May 2024DividendInterim Dividend - Rs. - 26.0000 — ₹26.00/share
22 May 2024DividendSpecial Dividend - Rs. - 10.0000 — ₹10.00/share
6 Nov 2023DividendInterim Dividend - Rs. - 22.0000 — ₹22.00/share
19 May 2023DividendInterim Dividend - Rs. - 21.0000 — ₹21.00/share
31 Oct 2022DividendInterim Dividend - Rs. - 18.0000 — ₹18.00/share
5 May 2022DividendInterim Dividend - Rs. - 21.0000 — ₹21.00/share
1 Nov 2021DividendInterim Dividend - Rs. - 19.0000 — ₹19.00/share
30 Mar 2021DividendInterim Dividend - Rs. - 20.0000 — ₹20.00/share
29 Oct 2020DividendInterim Dividend - Rs. - 18.0000 — ₹18.00/share
1 Jun 2020DividendInterim Dividend - Rs. - 16.0000 — ₹16.00/share
5 Nov 2019DividendInterim Dividend - Rs. - 12.0000 — ₹12.00/share
4 Jun 2019DividendInterim Dividend - Rs. - 8.0000 — ₹8.00/share
5 Apr 2019DividendInterim Dividend - Rs. - 7.0000 — ₹7.00/share
5 Nov 2018DividendInterim Dividend - Rs. - 8.0000 — ₹8.00/share
29 May 2018DividendInterim Dividend - Rs. - 11.0000 — ₹11.00/share
20 Mar 2018DividendInterim Dividend - Rs. - 5.0000 — ₹5.00/share
18 Dec 2017DividendInterim Dividend - Rs. - 4.0000 — ₹4.00/share
25 Oct 2017DividendInterim Dividend - Rs. - 4.0000 — ₹4.00/share
10 Apr 2017DividendInterim Dividend - Rs. - 3.0000 — ₹3.00/share
15 Dec 2016DividendInterim Dividend - Rs. - 3.0000 — ₹3.00/share
Section 06 · Business performance

Is it becoming more profitable?

EBITDA margin was 32.5% in FY2026, against 28.5% in FY2019. ROE was 81.6% and ROCE 112% in FY2026.

Margins — FY19 to FY26% of revenue · consolidated
0%5%10%15%20%25%30%35%32.5%21.6%FY19FY20FY21FY22FY23FY24FY25FY26
EBITDA marginNet margin
Strength

ROE of 81.6% is well above the personal care median of 19.9%.

Rule ROE_ABOVE_PEER_MEDIAN

EBITDA margin now
32.5%
8-year range
27.6–34.8%
ROE FY2026
81.6%
ROCE FY2026
111.6%

EBITDA margin fell from 34.7% to 32.5% of revenue.

EBITDA margin has ranged from 27.6% to 34.8% over 7 years and sits at 32.5% now.

Section 07 · Financial health

Is financial health improving?

It had little or no debt in FY2026 (debt-to-equity 0.00x). Operating cash flow was 1.36x net profit.

Net worth — FY19 to FY26₹ crore · consolidated
₹'000 crtotal debt ≈ ₹0 across the history01121kFY192kFY201kFY212kFY222kFY232kFY242kFY252kFY26
Net worth (shareholders' funds)
Strength

Free cash flow has been positive in 6 of the last 6 years.

Rule FCF_CONSISTENTLY_POSITIVE

Operating cash flow vs net profit₹ crore · FY21–FY26
0k1k1k2k7841kFY212k1kFY221k1kFY231k1kFY241k1kFY252k1kFY26
Operating cash flowNet profit
Total debt
₹0 crnet cash
Operating cash flow ÷ net profit
1.36×FY2026
Free cash flow
₹1,730 cr
Current ratio
1.28×
Section 08 · Relative position

How does it compare with peers?

Within its 3-company Personal Care peer group, it ranks 1 of 3 on return on equity and 1 of 3 on EBITDA margin. Its P/E of 35.2 compares with a peer median of 35.2.

Ranked against 3 personal care (FY2026, consolidated). No peer-relative rule fired for this company.

Revenue growth

COLPAL · 3rd of 3 · set median 5.0%

GODREJCP5.7%DABUR5.0%COLPAL-0.1%

EBITDA margin

COLPAL · 1st of 3 · set median 23.1%

COLPAL32.5%DABUR23.1%GODREJCP22.5%

Return on equity

COLPAL · 1st of 3 · set median 16.2%

COLPAL81.6%DABUR16.2%GODREJCP15.1%

P/E ratio

COLPAL · 2nd of 3 · set median 35.2×

DABUR34.9×COLPAL35.2×GODREJCP47.6×
P / E
35.2×TTM to Sept 26
P / B
30.2×latest book
P / S
7.5×TTM sales
Earnings yield
2.8%TTM to Sept 26

On the trailing twelve months. Last full year: P/E 36.1× · P/S 7.8× · ROE 81.6%.

Section 09 · The stock

How has the stock performed?

The share price is down 19.2% over 1 year, down 19.2% over 3 years (−6.9% a year) and up 19.2% over 5 years (3.6% a year). These are price changes excluding dividends, adjusted for splits and bonuses, to 20 Nov 2026; it is 23.3% below its 52-week high.

Adjusted close — 2020-01 to 2026-11₹ per share · split / bonus adjusted
0k4k₹1,7612020202120222023202420252026

Long-term price performance is shown above.

1-year return
−19.2%
3-year return
−19.2%
5-year return
+19.2%
From 52-wk high
−23.3%
Section 10 · Technical data

What does the technical data say?

Price-action indicators as of 2026-11-20. Secondary to the fundamentals above — included for timing context, not as a signal.

vs 50-day avg
Above₹1,751
vs 200-day avg
Below₹1,972
RSI (14)
56.4neutral
MACD histogram
16.7
From 52-wk high
−23.3%
From 52-wk low
+11.9%
30-day volatility
33.2%ann.
6-month return
−19.4%
RSI (14) · 0–10056.4 — neutral
0305070100OVERSOLDOVERBOUGHT56.4
Section 11 · Open questions

What should I investigate further?

Observations the engine tagged watch or deteriorating — prompts for your own research, not conclusions.

  • Concern
    Margins compressing
    EBITDA margin fell from 34.7% to 32.5% of revenue.
    MARGIN_COMPRESSED_YOY · conviction 40
  • Cash-flow-statement facts are unavailable for FY2019, FY2020 — those filings predate SEBI's Cash Flow Statement disclosure requirement. All other loaded years carry full P&L, balance sheet and cash-flow data.
Section 12 · Reference

The numbers

The full statements, kept deliberately secondary. Every figure traces to a BSE Integrated Filing (inline XBRL); ratios are recomputed from the normalised facts.

Income & balance sheet — ₹ crore, consolidated
MetricFY19FY20FY21FY22FY23FY24FY25FY26
Revenue4,4624,5254,8415,1005,2265,6806,0406,035
Total income4,5004,5744,8725,1265,2805,7576,1796,124
EBITDA1,2741,2511,5401,5921,6011,9772,0971,959
Profit before tax1,1431,0431,3501,4091,4101,7811,9301,784
Net profit7768161,0351,0781,0471,3241,4371,325
EPS (₹)28.530.038.139.638.548.752.848.7
Net worth1,4471,5941,1661,7351,7161,8741,6641,584
Total debt780000000
Operating cash flow——7841,6261,1761,1991,3941,806
Free cash flow——7261,5761,1071,1231,3231,730
Key ratios — consolidated
RatioFY19FY20FY21FY22FY23FY24FY25FY26
Growth
Revenue growth YoY—1.47.05.32.58.76.3-0.1
Profit growth YoY—5.326.84.1-2.926.48.5-7.8
Profitability
EBITDA margin %28.527.631.831.230.634.834.732.5
Net margin %17.217.821.321.019.823.023.321.6
Return on equity %53.653.775.074.460.773.781.281.6
Return on capital %73.167.598.497.682.6100.6109.3111.6
Leverage & cash
Debt to equity0.050.000.000.000.000.000.000.00
Cash flow ÷ profit——0.761.511.120.910.971.36
Current ratio0.961.160.851.371.431.781.651.28
Financials: BSE Integrated Filing inline XBRL (SEBI taxonomy), normalised to standard metric keys. Prices: end-of-day — history loaded from NSE end-of-day files, new days from the BSE bhavcopy; raw OHLC preserved; a corporate-action factor produces the adjusted series. The insight engine writes factual observations from fixed rules — it does not make recommendations. Not investment advice.